Choroidal Neovascularization Market Report by Product Type (Intravenous, Intravitreal), Diagnosis (Fluorescein Angiography (FA), Indocyanine Green (ICG) Angiography, Spectral Domain Optical Coherence Tomography (OCT), and Others), Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser photocoagulation, Low-dose Radiation Therapy, Surgery), Application (Extreme Myopia, Malignant Myopic Degeneration, Age-Related Developments), and Region 2025-2033

Choroidal Neovascularization Market Report by Product Type (Intravenous, Intravitreal), Diagnosis (Fluorescein Angiography (FA), Indocyanine Green (ICG) Angiography, Spectral Domain Optical Coherence Tomography (OCT), and Others), Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser photocoagulation, Low-dose Radiation Therapy, Surgery), Application (Extreme Myopia, Malignant Myopic Degeneration, Age-Related Developments), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A2561

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Choroidal Neovascularization Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Intravenous
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Intravitreal
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Type of Diagnosis
    7.1    Fluorescein Angiography (FA)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Indocyanine Green (ICG) Angiography
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Spectral Domain Optical Coherence Tomography (OCT)
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Treatment Type
    8.1    Angiogenesis Inhibitors Injection
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Photodynamic Therapy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Laser Photocoagulation
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Low-dose Radiation Therapy
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Surgery
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by Application
    9.1    Extreme Myopia
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Malignant Myopic Degeneration
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Age-Related Developments
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Bausch Health Companies Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Bayer AG
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Gilead Sciences, Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche AG
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 SWOT Analysis
        15.3.5   MaaT Pharma
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Novartis AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Pfizer Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Regeneron Pharmaceuticals Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio

List of Figures

Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2024
Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2024
Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2024
Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2024
Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2024
Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
Figure 87: Global: Choroidal Neovascularization Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million USD), 2025-2033
Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Choroidal Neovascularization Market Structure
Table 8: Global: Choroidal Neovascularization Market: Key Players

Choroidal Neovascularization Market Report by Product Type (Intravenous, Intravitreal), Diagnosis (Fluorescein Angiography (FA), Indocyanine Green (ICG) Angiography, Spectral Domain Optical Coherence Tomography (OCT), and Others), Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser photocoagulation, Low-dose Radiation Therapy, Surgery), Application (Extreme Myopia, Malignant Myopic Degeneration, Age-Related Developments), and Region 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials